Advasa Receives Nasdaq Bid-Price Deficiency Notice, Has 180 Days to Regain $1.00 Compliance
ADBT sits 34% above its 52-week low of $0.093 on light trading volume (0.1× avg).
Summary
Advasa received a Nasdaq notice on October 21, 2026 that its stock had been below the $1.00 minimum bid for 30 consecutive business days. The company has until April 19, 2027 to regain compliance or face a transfer to the Nasdaq Capital Market and possible delisting.
Key Events · Legal and Risk Events · ADBT
-
Nasdaq Bid-Price Deficiency Notice
Nasdaq notified Advasa on October 21, 2026 that its common stock had closed below the $1.00 minimum bid price for 30 consecutive business days, breaching Listing Rule 5450(a)(1).
-
180-Day Cure Window to April 19, 2027
To regain compliance, Advasa must post a closing bid of at least $1.00 for a minimum of ten consecutive business days before the April 19, 2027 deadline.
-
Fallback Is Nasdaq Capital Market Transfer
Absent compliance, the company may transfer to the Nasdaq Capital Market provided it meets that market's publicly held shares requirement and other initial listing standards; failing that, Nasdaq would issue a delisting determination subject to appeal.
-
Trading Continues Uninterrupted for Now
The notice has no immediate effect on listing or trading, and ADBT continues to trade on the Nasdaq Global Market.
Analysis · ADBT · Technology
The clock is now formally running: after Advasa's stock traded below $1.00 for 30 straight business days, Nasdaq has given the company until April 19, 2027 to close at or above $1.00 for ten consecutive business days, failing which it must shift to the Nasdaq Capital Market and eventually face delisting proceedings. Trading does not halt today, but the notice imposes a hard deadline on a stock now quoted around $0.125 — leaving a reverse split or a sustained re-rating as the likely paths to staying on the Global Market. For holders, the practical risk is a forced share consolidation or a move to a less liquid tier, either of which reshapes the share structure and the investor base.
How filings like this one have moved
In the 30 days to Oct 27, 2026, 36.2% of the 898 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.75%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ADBT was trading at $0.13 on NASDAQ in the Technology sector, with a market capitalization of approximately $61.4M. The 52-week trading range was $0.09 to $13.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.